A number of drugs that are used recreationally are now being studied for their use in psychopharmacology. But while the ways in which these drugs are similar or different has been described anecdotally by recreational users, they haven’t been studied in comparison to one another. Dr. Matthias Liechti and his team of researchers recently published a study in the journal Neuropsychopharmacology, in which 28 healthy subjects, men and women, take doses of LSD, MDMA, amphetamines, and a placebo over four different sessions. Dr. Liechti says this blinding is important; in other studies, participants either have taken a drug or a placebo and can tell when they’re taking the drug. But in this case they don’t know which drug they’re taking, which allows the effects of the drugs to be compared against each other. Take a listen to find out more!
For information regarding your data privacy, visit acast.com/privacyBig data in psychiatry: multiomics, neuroimaging, computational modeling, and digital phenotyping
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Big behavior: challenges and opportunities in a new era of deep behavior profiling
Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders
Pubertal adversity alters chromatin dynamics and stress circuitry in the pregnant brain
Social networking and mental health: looking beyond frequency of use and towards mechanisms of action
Chronic opioid pretreatment potentiates the sensitization of fear learning by trauma
Effects of MDMA on attention to positive social cues and pleasantness of affective touch.
Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial.
Cues play a critical role in estrous cycle-dependent enhancement of cocaine reinforcement
Food Addiction: A Valid Concept?
Sex Matters
Recent advances in the study of aggression
Neurocognitive effects of umami: association with eating behavior and food choice
Burst activation of dopamine neurons produces prolonged post-burst availability of actively released dopamine.
Debating the Persistence of Neurogenesis in Humans
Considerations for the Use of DREADDs in Behavioral Neuroscience
Neuropsychopharmacology Reviews: Cannabis and Cannabinoids: From Synapse to Society
Opioid Release after High-Intensity Interval Training in Healthy Human Subjects
Create your
podcast in
minutes
It is Free